Iron Deficiency Anemia Therapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: I3A6EAE6552EEN
Market Monitor Global

Abstracts

Iron deficiency anemia is anemia that occurs when iron stores cannot meet the needs of normal red blood cell production.This is due to insufficient iron intake, reduced absorption, increased demand, and excess iron deficiency or loss.The morphology is small cell hypochromic anemia.Iron deficiency anemia is not a disease, but the symptoms of the disease, symptoms and anemia degree and onset of the delay related.

This report contains market size and forecasts of Iron Deficiency Anemia Therapy in Global, including the following market information:

Global Iron Deficiency Anemia Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Iron Deficiency Anemia Therapy market was valued at 2854.1 million in 2021 and is projected to reach US$ 4022.5 million by 2028, at a CAGR of 5.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Iron Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Iron Deficiency Anemia Therapy include Allergan, AMAG Pharmaceuticals, Integra Lifesciences, Galderma Pharma, Teoxane, Sinclair Pharma, Pieris, Pharmacosmos AS and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Iron Deficiency Anemia Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Iron Deficiency Anemia Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Iron Deficiency Anemia Therapy Market Segment Percentages, by Type, 2021 (%)

• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusion
• Other

Global Iron Deficiency Anemia Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Iron Deficiency Anemia Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Home Healthcare
• Other

Global Iron Deficiency Anemia Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Iron Deficiency Anemia Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Iron Deficiency Anemia Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Iron Deficiency Anemia Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• AMAG Pharmaceuticals
• Integra Lifesciences
• Galderma Pharma
• Teoxane
• Sinclair Pharma
• Pieris
• Pharmacosmos AS
• Johnson & Johnson
• Luitpold Pharmaceuticals
• Keryx Biopharmaceuticals
• Vifor Pharma
• Akebia Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Iron Deficiency Anemia Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Iron Deficiency Anemia Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IRON DEFICIENCY ANEMIA THERAPY OVERALL MARKET SIZE

2.1 Global Iron Deficiency Anemia Therapy Market Size: 2021 VS 2028
2.2 Global Iron Deficiency Anemia Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Iron Deficiency Anemia Therapy Players in Global Market
3.2 Top Global Iron Deficiency Anemia Therapy Companies Ranked by Revenue
3.3 Global Iron Deficiency Anemia Therapy Revenue by Companies
3.4 Top 3 and Top 5 Iron Deficiency Anemia Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Iron Deficiency Anemia Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Iron Deficiency Anemia Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Iron Deficiency Anemia Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Iron Deficiency Anemia Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Iron Deficiency Anemia Therapy Market Size Markets, 2021 & 2028
  4.1.2 Oral Iron Therapy
  4.1.3 Parenteral Iron Therapy
  4.1.4 Red Blood Cell Transfusion
  4.1.5 Other
4.2 By Type - Global Iron Deficiency Anemia Therapy Revenue & Forecasts
  4.2.1 By Type - Global Iron Deficiency Anemia Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Iron Deficiency Anemia Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Iron Deficiency Anemia Therapy Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Home Healthcare
  5.1.5 Other
5.2 By Application - Global Iron Deficiency Anemia Therapy Revenue & Forecasts
  5.2.1 By Application - Global Iron Deficiency Anemia Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Iron Deficiency Anemia Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Iron Deficiency Anemia Therapy Market Size, 2021 & 2028
6.2 By Region - Global Iron Deficiency Anemia Therapy Revenue & Forecasts
  6.2.1 By Region - Global Iron Deficiency Anemia Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Iron Deficiency Anemia Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Iron Deficiency Anemia Therapy Revenue, 2017-2028
  6.3.2 US Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.3.3 Canada Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.3.4 Mexico Iron Deficiency Anemia Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Iron Deficiency Anemia Therapy Revenue, 2017-2028
  6.4.2 Germany Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.4.3 France Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.4.4 U.K. Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.4.5 Italy Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.4.6 Russia Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.4.8 Benelux Iron Deficiency Anemia Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Iron Deficiency Anemia Therapy Revenue, 2017-2028
  6.5.2 China Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.5.3 Japan Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.5.4 South Korea Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.5.6 India Iron Deficiency Anemia Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Iron Deficiency Anemia Therapy Revenue, 2017-2028
  6.6.2 Brazil Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.6.3 Argentina Iron Deficiency Anemia Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Iron Deficiency Anemia Therapy Revenue, 2017-2028
  6.7.2 Turkey Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.7.3 Israel Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Iron Deficiency Anemia Therapy Market Size, 2017-2028
  6.7.5 UAE Iron Deficiency Anemia Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Iron Deficiency Anemia Therapy Major Product Offerings
  7.1.4 Allergan Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 AMAG Pharmaceuticals
  7.2.1 AMAG Pharmaceuticals Corporate Summary
  7.2.2 AMAG Pharmaceuticals Business Overview
  7.2.3 AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Major Product Offerings
  7.2.4 AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.2.5 AMAG Pharmaceuticals Key News
7.3 Integra Lifesciences
  7.3.1 Integra Lifesciences Corporate Summary
  7.3.2 Integra Lifesciences Business Overview
  7.3.3 Integra Lifesciences Iron Deficiency Anemia Therapy Major Product Offerings
  7.3.4 Integra Lifesciences Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.3.5 Integra Lifesciences Key News
7.4 Galderma Pharma
  7.4.1 Galderma Pharma Corporate Summary
  7.4.2 Galderma Pharma Business Overview
  7.4.3 Galderma Pharma Iron Deficiency Anemia Therapy Major Product Offerings
  7.4.4 Galderma Pharma Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.4.5 Galderma Pharma Key News
7.5 Teoxane
  7.5.1 Teoxane Corporate Summary
  7.5.2 Teoxane Business Overview
  7.5.3 Teoxane Iron Deficiency Anemia Therapy Major Product Offerings
  7.5.4 Teoxane Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.5.5 Teoxane Key News
7.6 Sinclair Pharma
  7.6.1 Sinclair Pharma Corporate Summary
  7.6.2 Sinclair Pharma Business Overview
  7.6.3 Sinclair Pharma Iron Deficiency Anemia Therapy Major Product Offerings
  7.6.4 Sinclair Pharma Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.6.5 Sinclair Pharma Key News
7.7 Pieris
  7.7.1 Pieris Corporate Summary
  7.7.2 Pieris Business Overview
  7.7.3 Pieris Iron Deficiency Anemia Therapy Major Product Offerings
  7.7.4 Pieris Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.7.5 Pieris Key News
7.8 Pharmacosmos AS
  7.8.1 Pharmacosmos AS Corporate Summary
  7.8.2 Pharmacosmos AS Business Overview
  7.8.3 Pharmacosmos AS Iron Deficiency Anemia Therapy Major Product Offerings
  7.8.4 Pharmacosmos AS Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.8.5 Pharmacosmos AS Key News
7.9 Johnson & Johnson
  7.9.1 Johnson & Johnson Corporate Summary
  7.9.2 Johnson & Johnson Business Overview
  7.9.3 Johnson & Johnson Iron Deficiency Anemia Therapy Major Product Offerings
  7.9.4 Johnson & Johnson Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.9.5 Johnson & Johnson Key News
7.10 Luitpold Pharmaceuticals
  7.10.1 Luitpold Pharmaceuticals Corporate Summary
  7.10.2 Luitpold Pharmaceuticals Business Overview
  7.10.3 Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Major Product Offerings
  7.10.4 Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.10.5 Luitpold Pharmaceuticals Key News
7.11 Keryx Biopharmaceuticals
  7.11.1 Keryx Biopharmaceuticals Corporate Summary
  7.11.2 Keryx Biopharmaceuticals Business Overview
  7.11.3 Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Major Product Offerings
  7.11.4 Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.11.5 Keryx Biopharmaceuticals Key News
7.12 Vifor Pharma
  7.12.1 Vifor Pharma Corporate Summary
  7.12.2 Vifor Pharma Business Overview
  7.12.3 Vifor Pharma Iron Deficiency Anemia Therapy Major Product Offerings
  7.12.4 Vifor Pharma Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.12.5 Vifor Pharma Key News
7.13 Akebia Therapeutics
  7.13.1 Akebia Therapeutics Corporate Summary
  7.13.2 Akebia Therapeutics Business Overview
  7.13.3 Akebia Therapeutics Iron Deficiency Anemia Therapy Major Product Offerings
  7.13.4 Akebia Therapeutics Iron Deficiency Anemia Therapy Revenue in Global Market (2017-2022)
  7.13.5 Akebia Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Iron Deficiency Anemia Therapy Market Opportunities & Trends in Global Market
Table 2. Iron Deficiency Anemia Therapy Market Drivers in Global Market
Table 3. Iron Deficiency Anemia Therapy Market Restraints in Global Market
Table 4. Key Players of Iron Deficiency Anemia Therapy in Global Market
Table 5. Top Iron Deficiency Anemia Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Iron Deficiency Anemia Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Iron Deficiency Anemia Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Iron Deficiency Anemia Therapy Product Type
Table 9. List of Global Tier 1 Iron Deficiency Anemia Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Iron Deficiency Anemia Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Iron Deficiency Anemia Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Iron Deficiency Anemia Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Iron Deficiency Anemia Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Iron Deficiency Anemia Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Iron Deficiency Anemia Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Iron Deficiency Anemia Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Iron Deficiency Anemia Therapy Product Offerings
Table 32. Allergan Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 33. AMAG Pharmaceuticals Corporate Summary
Table 34. AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Product Offerings
Table 35. AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Integra Lifesciences Corporate Summary
Table 37. Integra Lifesciences Iron Deficiency Anemia Therapy Product Offerings
Table 38. Integra Lifesciences Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Galderma Pharma Corporate Summary
Table 40. Galderma Pharma Iron Deficiency Anemia Therapy Product Offerings
Table 41. Galderma Pharma Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Teoxane Corporate Summary
Table 43. Teoxane Iron Deficiency Anemia Therapy Product Offerings
Table 44. Teoxane Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Sinclair Pharma Corporate Summary
Table 46. Sinclair Pharma Iron Deficiency Anemia Therapy Product Offerings
Table 47. Sinclair Pharma Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Pieris Corporate Summary
Table 49. Pieris Iron Deficiency Anemia Therapy Product Offerings
Table 50. Pieris Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Pharmacosmos AS Corporate Summary
Table 52. Pharmacosmos AS Iron Deficiency Anemia Therapy Product Offerings
Table 53. Pharmacosmos AS Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Johnson & Johnson Corporate Summary
Table 55. Johnson & Johnson Iron Deficiency Anemia Therapy Product Offerings
Table 56. Johnson & Johnson Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Luitpold Pharmaceuticals Corporate Summary
Table 58. Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Product Offerings
Table 59. Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Keryx Biopharmaceuticals Corporate Summary
Table 61. Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Product Offerings
Table 62. Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Vifor Pharma Corporate Summary
Table 64. Vifor Pharma Iron Deficiency Anemia Therapy Product Offerings
Table 65. Vifor Pharma Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Akebia Therapeutics Corporate Summary
Table 67. Akebia Therapeutics Iron Deficiency Anemia Therapy Product Offerings
Table 68. Akebia Therapeutics Iron Deficiency Anemia Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Iron Deficiency Anemia Therapy Segment by Type in 2021
Figure 2. Iron Deficiency Anemia Therapy Segment by Application in 2021
Figure 3. Global Iron Deficiency Anemia Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Iron Deficiency Anemia Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Iron Deficiency Anemia Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Iron Deficiency Anemia Therapy Revenue in 2021
Figure 8. By Type - Global Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 12. US Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 24. China Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Iron Deficiency Anemia Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Iron Deficiency Anemia Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Integra Lifesciences Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Galderma Pharma Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teoxane Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sinclair Pharma Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pieris Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pharmacosmos AS Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson & Johnson Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Vifor Pharma Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Akebia Therapeutics Iron Deficiency Anemia Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)